Impaired hormonal responses to hypoglycemia in spontaneously diabetic and recurrently hypoglycemic rats. Reversibility and stimulus specificity of the deficits
- PMID: 8254023
- PMCID: PMC288464
- DOI: 10.1172/JCI116883
Impaired hormonal responses to hypoglycemia in spontaneously diabetic and recurrently hypoglycemic rats. Reversibility and stimulus specificity of the deficits
Abstract
To evaluate the roles of iatrogenic hypoglycemia and diabetes per se in the pathogenesis of defective hormonal counterregulation against hypoglycemia in insulin-dependent diabetes mellitus (IDDM), nondiabetic, and spontaneously diabetic BB/Wor rats were studied using a euglycemic/hypoglycemic clamp. In nondiabetic rats, recurrent (4 wk) insulin-induced hypoglycemia (mean daily glucose, MDG, 59 mg/dl) dramatically reduced glucagon and epinephrine responses by 84 and 94%, respectively, to a standardized glucose fall from 110 to 50 mg/dl. These deficits persisted for > 4 d after restoring normoglycemia, and were specific for hypoglycemia, with normal glucagon and epinephrine responses to arginine and hypovolemia, respectively. After 4 wk of normoglycemia, hormonal counterregulation increased, with the epinephrine, but not the glucagon response reaching control values. In diabetic BB rats (MDG 245 mg/dl with intermittent hypoglycemia), glucagon and epinephrine counterregulation were reduced by 86 and 90%, respectively. Chronic iatrogenic hypoglycemia (MDG 52 mg/dl) further suppressed counterregulation. Prospective elimination of hypoglycemia (MDG 432 mg/dl) improved, but did not normalize hormonal counterregulation. In diabetic rats, the glucagon defect appeared to be specific for hypoglycemia, whereas deficient epinephrine secretion also occurred during hypovolemia. We concluded that both recurrent hypoglycemia and the diabetic state independently lead to defective hormonal counterregulation. These data suggest that in IDDM iatrogenic hypoglycemia magnifies preexisting counterregulatory defects, thereby increasing the risk of severe hypoglycemia.
Similar articles
-
Opiate blockade enhances hypoglycemic counterregulation in normal and insulin-dependent diabetic subjects.Am J Physiol. 1991 Jun;260(6 Pt 1):E852-8. doi: 10.1152/ajpendo.1991.260.6.E852. Am J Physiol. 1991. PMID: 2058661
-
Chronic hypoglycemia and diabetes impair counterregulation induced by localized 2-deoxy-glucose perfusion of the ventromedial hypothalamus in rats.Diabetes. 1999 Mar;48(3):584-7. doi: 10.2337/diabetes.48.3.584. Diabetes. 1999. PMID: 10078560
-
Role of epinephrine-mediated beta-adrenergic mechanisms in hypoglycemic glucose counterregulation and posthypoglycemic hyperglycemia in insulin-dependent diabetes mellitus.J Clin Invest. 1982 Feb;69(2):315-26. doi: 10.1172/jci110455. J Clin Invest. 1982. PMID: 6120181 Free PMC article.
-
Evaluation of hypoglycemic counterregulation using a modification of the Andres glucose clamp.Exp Gerontol. 1993 Jul-Oct;28(4-5):371-80. doi: 10.1016/0531-5565(93)90064-k. Exp Gerontol. 1993. PMID: 8224035 Review.
-
Hierarchy of physiological responses to hypoglycemia: relevance to clinical hypoglycemia in type I (insulin dependent) diabetes mellitus.Horm Metab Res. 1997 Mar;29(3):92-6. doi: 10.1055/s-2007-978997. Horm Metab Res. 1997. PMID: 9137976 Review.
Cited by
-
Combined corticotropin-releasing hormone and glucocorticoid deficiency does not enhance counterregulatory responses after recurrent hypoglycemia in mice.Metabolism. 2005 Sep;54(9):1259-65. doi: 10.1016/j.metabol.2005.04.013. Metabolism. 2005. PMID: 16125539 Free PMC article.
-
Hypoglycemia in type 1 diabetes.Diabetes. 2010 Oct;59(10):2333-9. doi: 10.2337/db10-0103. Diabetes. 2010. PMID: 20876723 Free PMC article. No abstract available.
-
Ventromedial hypothalamic nitric oxide production is necessary for hypoglycemia detection and counterregulation.Diabetes. 2010 Feb;59(2):519-28. doi: 10.2337/db09-0421. Epub 2009 Nov 23. Diabetes. 2010. PMID: 19934009 Free PMC article.
-
Prevention of an increase in plasma cortisol during hypoglycemia preserves subsequent counterregulatory responses.J Clin Invest. 1997 Jul 15;100(2):429-38. doi: 10.1172/JCI119550. J Clin Invest. 1997. PMID: 9218521 Free PMC article.
-
Somatostatin Receptor Antagonism Reverses Glucagon Counterregulatory Failure in Recurrently Hypoglycemic Male Rats.Endocrinology. 2021 Dec 1;162(12):bqab189. doi: 10.1210/endocr/bqab189. Endocrinology. 2021. PMID: 34477204 Free PMC article.